FINDEX Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from FINDEX Inc.'s yearly results (2022–2025), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 92% of Healthcare companies in Japan.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 5.0 times. Higher than 89% of Healthcare companies in Japan.
- Growth Efficiency Ratio: Sales grew 35% in 3 years; of every extra ¥100 of sales, ¥34 became extra profit. Higher than 87% of Healthcare companies in Japan.
Cash quality
Profit Cash Ratio
¥126Over the last 3 years, every ¥100 of reported profit came with ¥126 of operating cash.
Lower than 52% of Healthcare companies in Japan.
Self-Funding Ratio
5.0×Over the last 3 years its own operating cash covered its investment spending (capex) 5.0 times.
Higher than 89% of Healthcare companies in Japan.
Cash Locked Ratio
¥10For every ¥100 of sales, ¥10 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥21 tied up three years earlier.
Less money tied up than 59% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 92% of Healthcare companies in Japan.
Growth Efficiency Ratio
¥34Sales grew 35% in 3 years; of every extra ¥100 of sales, ¥34 became extra profit.
Higher than 87% of Healthcare companies in Japan.
Asset Productivity Ratio
+35% / +37%In 3 years sales changed by +35% while total assets changed by +37%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
96%Of every ¥100 the company owns, ¥96 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 58% of Healthcare companies in Japan.
Tangible Net Worth Ratio
94%Of every ¥100 of net worth, ¥94 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 51% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
FINDEX Inc. owes ¥0.18 for every ¥1 it owns. Net profit rose 8% in the year to Dec 2025, and grew 20% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Dec 2025.
P/E ratio
19.2Investors pay ¥19.2 for every ¥1 of FINDEX Inc.'s yearly profit, higher than 65% of Healthcare companies in Japan.
P/B ratio
3.72The share price is 3.72 times FINDEX Inc.'s book value per share, higher than 83% of Healthcare companies in Japan.
Market cap
¥21.1 BThe total market value of all of FINDEX Inc.'s shares at today's price (share price × number of shares), larger than 52% of Healthcare companies in Japan. PosiCap size class: Mini Cap.
Net worth (book value)
¥5.7 BWhat FINDEX Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥231.43Net worth divided by the number of shares. The share price of ¥862.00 is 3.7 times this, which is the P/B above.
Return on equity (ROE)
20.2%FINDEX Inc. earned 20.2% on its shareholders' money over the last year, higher than 90% of Healthcare companies in Japan.
Owes vs Owns
0.18×FINDEX Inc. owes ¥0.18 for every ¥1 it owns (low), lower than 81% of Healthcare companies in Japan.
Dividend yield
3.17%FINDEX Inc. pays 3.17% of its share price as dividends a year, higher than 61% of dividend-paying Healthcare companies in Japan.
Revenue growth
+5%Revenue rose 5% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Profit growth
+8%Net profit rose 8% in the year to Dec 2025, and grew 20% a year on average over 3 years.
Profit margin
20.6%FINDEX Inc. keeps ¥21 of every ¥100 of revenue as net profit.
Cash quality
1.3×Cash from FINDEX Inc.'s business was 1.3× its reported profit in the year to Dec 2025 — its profit turned into cash.
Questions
What is FINDEX Inc.'s P/E ratio?
Investors pay ¥19.2 for every ¥1 of FINDEX Inc.'s yearly profit, higher than 65% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For FINDEX Inc.: ¥21.1 B ÷ ¥5.7 B (30 Jun 2026) = 3.7.
What is FINDEX Inc.'s return on equity?
FINDEX Inc. earned 20.2% on its shareholders' money over the last year, higher than 90% of Healthcare companies in Japan.
How much does FINDEX Inc. owe compared with what it owns?
FINDEX Inc. owes ¥0.18 for every ¥1 it owns (low), lower than 81% of Healthcare companies in Japan.
Does FINDEX Inc. pay a dividend?
Yes. FINDEX Inc. pays 3.17% of its share price as dividends a year, higher than 61% of dividend-paying Healthcare companies in Japan.
Is FINDEX Inc.'s revenue growing?
Revenue rose 5% in the year to Dec 2025, and grew 10% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.